A Phase III Study of GS101 Injection to Dupixent®

Inclusion Criteria

• •Subjects, male or female, between the ages of 18 and 75 years (inclusive)
• •At the time of screening, the diagnosis of atopic dermatitis (AD) meets the Hanifin-Rajka criteria, with a disease history for at least 1 year prior to screening
• •During the screening period and at baseline, patients with moderate-to-severe atopic dermatitis, defined as meeting all of the following 3 criteria concurrently: a. IGA score ≥ 3; b. EASI score ≥ 16; c. BSA ≥ 10%.